LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
Filter by:
  • All
  • News Releases
  • Articles & blogs
  • Ventures Funding
    • 12 April 2019

    Anti-Netrin-1 humanised antibody for osteolytic bone disease

    Project Aim First-in-class anti-netrin-1 humanised antibody for the treatment of atherosclerosis Advantage An anti-netrin-1 therapeutic offers the…